DOH: WHO-led COVID-19 vaccine trials to start in December
The World Health Organization's Solidarity Trial Phase 3 clinical trials for potential coronavirus vaccines will begin in December.
WHO has committed to announcing trial sites and other details within the week.
Russian manufacturer Gamaleya is still negotiating with a Philippine-based contract research organization for local vaccine manufacturing.
Chinese vaccine Sinovac has been cleared by the Vaccine Expert Panel of DOST, but must receive Ethics Board approval before applying for FDA clinical trial clearance.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics